Tracheobronchial Lung cancer

Auerbach O, Saccomanno G, Kuschner M, et al. 1978. Histologic findings in the tracheobronchial tree of uranium miners and non-miners with lung cancer. Cancer (Phila) 42 483-489. 

Song and co-workers (1999) placed their self-developed potentially retrievable covered metallic stent in eight patients with tracheobronchial malignant obstructions (esophageal cancer, n=4 lung cancer, n=2 tracheal cancer, n=l gastric cancer, n=l). Stents were successfully placed in all patients but one. In this case a hinged stent (combined tracheal and bronchial stent) was placed too caudal so... 

Zwischenberger JB, Wittich GR, van Sonnenberg E, Johnson RF, Alpard SK, Anand SK, Morrison RJ (1997) Airway simifiation to guide stent placement for tracheobronchial obstruction in lung cancer. Ann Thorac Surg 64 1619-1625... 

S. K. Anand, R.J. Morrison, Airway simulation to guide stent placement for tracheobronchial obstmction in lung cancer, Ann. Thorac. Surg. 64 (6) (December 1997)... 

Research results summarized in Sections 8-10 strongly indicate that bryostatin 1 and/or others in the series may prove to be clinically useful for treatment of cancer and certain other medical problems. Recently, bryostatin 1 has been found to inhibit six of seven fresh human myeloid leukemia specimens 74 prevent (whereas the phorbol PMA induces) squamous differentiation in human tracheobronchial epithelial cells (75), inhibit A549 human lung carcinoma cells 76) and very importantly induce differentiation of human B-chronic lymphocytic leukemia (CLL) cells (77, 78). The latter important contribution by Drexler and colleagues may open a clinical path to successfully treating the routinely fatal CLL. 

---